Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2025)

Mangoceuticals' Income from Non-Controlling Interests history spans 3 years, with the latest figure at -$558.0 for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests fell 21.04% year-over-year to -$558.0; the TTM value through Sep 2025 reached -$902.0, up 99.95%, while the annual FY2024 figure was -$1081.0, N/A changed from the prior year.
  • Income from Non-Controlling Interests for Q3 2025 was -$558.0 at Mangoceuticals, down from -$2.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$2.0 in Q2 2025 and bottomed at -$1.8 million in Q3 2023.
  • The 3-year median for Income from Non-Controlling Interests is -$292.0 (2024), against an average of -$225149.9.
  • The largest annual shift saw Income from Non-Controlling Interests surged 99.97% in 2024 before it crashed 172.22% in 2025.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at -$1.8 million in 2023, then surged by 99.99% to -$244.0 in 2024, then plummeted by 128.69% to -$558.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Income from Non-Controlling Interests are -$558.0 (Q3 2025), -$2.0 (Q2 2025), and -$98.0 (Q1 2025).